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Objective: We evaluated the effect of a reduction in the systemic ratio of n-6:n-3 polyunsaturated fatty
acids (PUFAs) on changes in inﬂammation, glucose metabolism, and the idiopathic development of knee
osteoarthritis (OA) in mice. We hypothesized that a lower ratio of n-6:n-3 PUFAs would protect against
OA markers in cartilage and synovium, but not bone.
Design: Male and female fat-1 transgenic mice (Fat-1), which convert dietary n-6 to n-3 PUFAs endog-
enously, and their wild-type (WT) littermates were fed an n-6 PUFA enriched diet for 9e14 months. The
effect of gender and genotype on serum PUFAs, interleukin (IL)-6, tumor necrosis factor (TNF)-a, and
glucose tolerance was tested by 2-factor analysis of variance (ANOVA). Cortical and trabecular sub-
chondral bone changes were documented by micro-focal computed tomography (CT), and knee OA was
assessed by semi-quantitative histomorphometry grading.
Results: The n-6:n-3 ratio was reduced 12-fold and 7-fold in male and female Fat-1 mice, respectively,
compared to WT littermates. IL-6 and TNF-a levels were reduced modestly in Fat-1 mice. However, these
systemic changes did not reduce osteophyte development, synovial hyperplasia, or cartilage degenera-
tion. Also the fat-1 transgene did not alter subchondral cortical or trabecular bone morphology or bone
mineral density.
Conclusions: Reducing the systemic n-6:n-3 ratio does not slow idiopathic changes in cartilage, syno-
vium, or bone associated with early-stage knee OA in mice. The anti-inﬂammatory and anti-catabolic
effects of n-3 PUFAs previously reported for cartilage may be more evident at later stages of disease
or in post-traumatic and other inﬂammatory models of OA.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.o: T.M. Grifﬁn, Free Radical
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Inﬂammation mediates osteoarthritis (OA) pathogenesis
through a mosaic-like pattern of classical immune cell mediated
cytokine signaling and activation of molecular inﬂammatory path-
ways in native cells of intra-articular joint tissues1,2. While these
inﬂammatory responses are most evident in post-traumatic knee
OA3,4, they are also observed in primary knee OA, suggesting that
age-dependent changes in inﬂammatory pathways contribute to an
increase in OA risk5,6.
Recent studies suggest that chronic dietary factors can exacer-
bate or inhibit joint inﬂammation and thus may be importanttd. All rights reserved.
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risk factor for knee OA, and several recent studies indicate that
altered joint biomechanics alone are insufﬁcient to increase OA risk
with obesity7e10. While most studies have focused on adipokines as
systemic mediators of obesity-associated OA, lipids are also potent
regulatorsof inﬂammation11. Inparticular, the ratioof omega-6 (n-6)
to omega-3 (n-3) polyunsaturated fatty acids (PUFAs) is considered
one of the most important dietary mediators of inﬂammation12.
Arachidonic acid (AA), amajor n-6 PUFA, promotes inﬂammation by
being converted into pro-inﬂammatory eicosanoids, such as pros-
taglandins, thromboxanes, and leukotrines. In contrast, n-3 PUFAs
such as eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) inhibit inﬂammation and accelerate the resolution of
inﬂammation. The anti-inﬂammatory effects of n-3 PUFAs occur
through multiple mechanisms, including inhibition of the AA con-
version into pro-inﬂammatory eicosanoids, synthesis of anti-
inﬂammatory agents such as protectins and resolvins, and down-
regulation of pro-inﬂammatory gene expression through n-3 re-
ceptor G-protein coupled receptor (GPR) 12013,14. Thus, variation in
the dietary ratio of n-6:n-3 PUFAs, which is elevated in modern
Western diets15 and attributed to the increase in risk of numerous
chronic diseases16, may also contribute to differences in OA risk.
Previous studies supporta role forn-6andn-3PUFAs inmodifying
OA severity. In middle-aged individuals without clinical knee OA,
dietary intake of n-6 PUFAswas positively associatedwith the future
prevalence, but not the incidence, of subchondral bone marrow le-
sions17,18. In individuals who have or are at high risk for knee OA,
fasting plasma AAwas positively associated with synovitis, whereas
patella-femoral cartilage loss was negatively associated with DHA19.
Animal and cell studies also indicate that n-3 PUFAs protect against
OA. Feeding an n-3 enriched diet to OA-prone DunkineHartley
Guinea pigs reducedmarkers of OAwithout altering OAmarkers in a
non-prone strain20. In addition, mice expressing the fat-1 transgene
were moderately protected from developing knee OA following
transection of the medial meniscus, medial collateral ligament, and
anterior crutiate ligament21. This transgene induces endogenous
conversion of n-6 to n-3 PUFAs by encoding a desaturase enzyme
absent in mammals that adds a double bond into the omega-3 po-
sition of an unsaturated fatty acid. The result is a systemic reduction
in the n-6:n-3 ratio22. The protective effects of the fat-1 transgene
was attributed to a reduction in inﬂammation, decreased protein
expression of matrix metalloproteinase-13 and A Disintegrin and
Metalloproteinase with Thrombospondin Motifs (ADAMTS)-5, and
enhanced autophagy21. In bovine cartilage explant and cell culture
models, EPA and DHA inhibited the expression of pro-inﬂammatory
and pro-catabolic genes and reduced glycosaminoglycan catabolism
induced byexposure to interleukin (IL)-123,24. Yet not all aspects of n-
3 PUFAs necessarily protect against OA. EPA and DHA levels are
positively associatedwith bone strength and bone density25,26, and a
low ratio of n-6:n-3 fatty acids protected against ovariectomy-
induced bone loss in mice27. These pro-anabolic effects of n-3
PUFAs on bone strength and mass may promote OA by stimulating
osteophyte development or subchondral bone thickening.
Our goal was to determine how a life-long reduction in the ratio
of n-6:n-3 PUFA levels affects the development of idiopathic knee
OA in mice. We hypothesized that a low ratio of n-6:n-3 PUFAs
protects against OA markers in cartilage and synovium, but not
bone. We tested this hypothesis using a transgenic mouse model
containing the fat-1 transgene from Caenorhabditis elegans22. By
feeding mice an n-6 PUFA-enriched diet, Fat-1 mice reduce the n-
6:n-3 ratio in the serum and tissues approximately 20-fold22. Here
we examined changes in serum lipids and inﬂammatory markers in
9e14 month-old male and female C57BL/6 mice with and without
the fat-1 transgene. We determined the effect of fat-1 transgene
expression on idiopathic knee OA changes in cartilage, bone, andsynovium. We also conducted regression analyses to evaluate
whether fat-1 expression altered associations between cartilage
and bone or synovium and bone OA outcome measures.
Materials and methods
Animals
We obtained fat-1 transgenic breeder mice from Dr JX Kang22.
Animals were bred while housed in the University of Oklahoma
Health Sciences Center (OUHSC) vivarium on a 12-h light/dark cycle
under temperature-controlled conditions (20e22C). Animals were
allowed ad libitum access to water and a modiﬁed AIN-76A puriﬁed
rodent diet supplemented with 10% Safﬂower oil by weight
(#180465; Dyets, Inc., Bethlehem, PA) as previously described28.
The diet contains 59% kcal carbohydrate, 18% kcal protein, and 23%
kcal fat, with an n-6:n-3 ratio of 27428. Wild-type (WT) (C57BL/6)
females were mated with male hemizygous fat-1þ/0 transgenic
mice maintained on a C57BL/6 background. Male and female lit-
termates carrying either one copy of the fat-1 gene (hereafter
referred to as Fat-1) or no copy of the fat-1 gene (WT) were studied.
Genotyping was conducted as previously described28. Our initial
cohort of animals (cohort 1) included the following number and
ages of animals: female WT mice (N ¼ 10; 59.6 ± 1.7 wks of age
[58e62 wks], mean ± SD [range]), female Fat-1 mice (N ¼ 10;
59.5 ± 1.6 wks of age [58e62 wks]), male WT mice (N ¼ 10;
55.4 ± 4.4 wks of age [52e61 wks]), and male Fat-1 mice (N ¼ 10;
57.7 ± 3.8 wks of age [51e61 wks]). Additional male mice were
included (cohort 2) to increase the sample size for lipid, cytokine,
and histologic analyses: maleWTmice (N¼ 8; 43.6 ± 4.3 wks of age
[36e48 wks]) and male Fat-1 mice (N ¼ 7; 43.1 ± 3.9 wks of age
[40e48 wks]). Although cohort 2 mice were younger than cohort 1,
no signiﬁcant age-dependent differences were observed so data
were pooled for both cohorts. Following euthanasia, the hind limbs
were dissected and stored in phosphate buffered saline at 80C.
All experimental procedures were conducted in accordance with a
protocol approved by the OUHSC Animal Care and Use Committee.
Serum analyses
Blood was collected from anesthetizedmice just before the mice
were killed. The blood was allowed to clot for 60 min at room
temperature and then centrifuged for 15 min at 3500 revolutions
per min, and the serum was aliquoted for immediate storage at
80C until analysis. Serum n-6 and n-3 PUFA analyses were per-
formed as previously described28. Brieﬂy, lipid classes of serum
lipid extracts were resolved, derivatized to form fatty acid methyl
esters, and analyzed using gaseliquid chromatography in an Agi-
lent 6890N gas chromatograph with ﬂame ionization detector (GC-
FID) (Agilent Technologies, Wilmington, DE). Authentic standards
(NU-CHEK PREP, Elysian, MN) were used to calculate relative mole
percentages for the following fatty acids: 20:4n6, 18:3n3, 20:5n3,
22:5n3, and 22:6n3. Serum concentrations of IL-6 and TNFa were
investigated as prognostic markers of the effect of fat-1 transgene
expression on systemic inﬂammation. They were measured using
quantitative enzyme linked immunosorbent assays (ELISA)
designed speciﬁcally for mice (eBioscience, San Diego, CA). All
samples were analyzed as recommended by the protocols provided
by the manufacturer. Glucose tolerance tests were conducted as
previously described29.
Micro-computed tomography (CT) analyses
Right knee joints of mice from Cohort 1 were thawed, ﬁxed in
10% neutral buffered formalin, and scanned using a micro-CT
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Fig. 1. Fat-1 transgene expression reduces n-6:n-3 serum fatty acids and systemic
cytokines. A. Fat-1 gene expression converts n-6 to n-3 fatty acids, resulting in a
dramatically reduced n-6:n-3 lipid ratio in male and female mice. B. Serum IL-6 con-
centrations are marginally reduced in Fat-1 mice (P ¼ 0.049) independent of animal
gender. C. Serum TNF-a is also reduced in Fat-1 mice (P ¼ 0.004) with the greatest
differences in female mice. Samples sizes in (A) are N ¼ 5, 14, 10, and 8 for WT male,
Fat-1 male, WT female, and Fat-1 female, respectively. Sample sizes in (B) and (C) are
N ¼ 16, 16, 10, and 10, respectively. P-values are from a 2-factor ANOVA; bars not
sharing the same letter are statistically different from each other as determined by
post-hoc analysis (HolmeSidak’s multiple comparison test). Values are mean ± 95% CI.
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described previously30. We quantiﬁed the following parameters for
the tibial epiphysis: subchondral bone thickness (mm), sub-
chondral bone density (mg hydroxyapatite/cm3), trabecular thick-
ness (mm), trabecular bone spacing (mm), trabecular bone volume
(BV, cm3), total trabecular volume (TV, cm3), and relative trabecular
bone volume (BV/TV). Bone outcome measures were evaluated
separately for the medial and lateral compartments.
Histomorphometric analyses
Following ﬁxation, intact knee joints from all animals were
processed and stained for histological grading as described previ-
ously30. OA severity scoring was conducted using a modiﬁed
Mankin scoring system31 for the following categories: changes in
articular cartilage structure (score of 0e11), Safranin O staining
(score of 0e8), tidemark duplication (score of 0e3) and hypertro-
phic chondrocytes (score of 0e2), for a maximum score of 24 per
location. Scores were recorded by three experienced graders under
blinded conditions at four locations within the jointdlateral fe-
mur, lateral tibia, medial femur, and medial tibia. We also quanti-
ﬁed the severity of osteophyte formation along the anterior and
posterior joint margins of the medial tibial plateau using a 0e3
histological grading scheme for each region as previously
described based on a visual scale of progressive bone deposition at
the peripheral osteochondral junction32. In addition, synovial
changes were determined by measuring synovial thickness (dis-
tance between synovial lining and joint capsule at the midpoint of
the anterior meniscus) and quantifying synovial extension into the
joint space. We quantiﬁed synovial extension as the presence (1) or
absence (0) of synovial tissue outgrowth parallel to the surface of
the meniscus. Extensions were evaluated along the meniscus
adjacent to the femoral and tibial surfaces in both the anterior and
posterior regions for a maximum score of 4. Scores were averaged
for two sections within the medial and lateral compartments per
animal.
Statistical analyses
All statistical analyses were conducted using either JMP 8.02
(SAS Institute, Cary, NC) or Prism 6 (GraphPad Software, La Jolla,
CA). The effect of the fat-1 genotype and sex were determined by
2-factor analysis of variance (ANOVA), with HolmeSidak's multiple
comparison's post-hoc test to determine group differences. When
cytokine concentrations were below the lowest levels of quantiﬁ-
cation (LLOQ), a value of one-half the LLOQ was used for statistical
purposes. Statistical analyses were performed on log-transformed
serum lipid and cytokine data to correct for non-normal distribu-
tions as determined by ShapiroeWilk normality test. An F test was
used to test for equality of variance betweenWTand Fat-1male and
female mice. Body weight and glucose areas under the curve (AUC)
comparisons between genotypes within a given sex were con-
ducted using two-tailed t tests, and blood glucose levels during the
glucose tolerance testing were analyzed by 2-way ANOVA with
time as a repeated measure. For semi-quantitative histological
scores, genotype and site-speciﬁc differences were determined
either by ManneWhitney U tests (cartilage) or a KruskaleWallis
test followed by Dunn's multiple comparisons test (osteophyte and
synovial hyperplasia).
We constructed exploratory pair-wise and multivariable
regression models to evaluate the effect of fat-1 transgene
expression on the association between cartilage and bone or
synovium and bone outcome measures. Pair-wise comparisons
were conducted using Spearman's Rho rank correlation analysis.
No signiﬁcant correlations were observed between any boneparameters (i.e., osteophyte score, subchondral bone thickness,
or relative trabecular bone volume) and either modiﬁed Mankin
OA scores or synovial thickness. Therefore, multivariable
regression analyses were conducted that adjusted for fat-1
expression and sex using Generalized Linear Modeling (GLM).
Models contained either the modiﬁed Mankin OA score or sy-
novial thickness as the outcome parameter. Osteophyte score,
subchondral bone thickness, or relative trabecular bone volume
were the independent predictors. For both pair-wise and GLM
analyses, OA scores were site-matched to the corresponding
bone parameter (e.g., medial tibial plateau OA score:osteophyte
score). Statistical signiﬁcance was reported at the 95% conﬁ-
dence level for all tests (P < 0.05). All data were reported as the
mean ± 95% conﬁdence intervals (CI).
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Fig. 2. Fat-1 transgene expression does not alter body weight or glucose tolerance in aged male AeC or female DeF mice. Body weight A, D and serum blood glucose clearance
following a fasted glucose tolerance test B, E were not signiﬁcantly different between either male or female WT and Fat-1 mice (P > 0.05). Both male and female WT and Fat-1 mice
produced similar glucose AUC values up to 120 min post glucose injection (C, F; mg/dL/min). N ¼ 10 per genotype and sex. Values are mean ± 95% CI.
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Serum n-6:n-3 PUFAs and cytokines
Fat-1 transgene expression signiﬁcantly reduced the n-6:n-3
PUFA ratio in male and female mice. In male mice, the n-6:n-3 ratio
decreased more than 12-fold, from 38.8 to 3.2 in WT vs Fat-1 mice,
respectively (P< 0.001; Fig.1(A)). This change in PUFA ratiowas due
to a 14% reduction in the relative mole percentage of AA
(17.6e15.2%) and a 9.7-fold increase in n-3 levels (0.50e4.87%). In
female mice, the n-6:n-3 ratio decreased nearly 7-fold, from 35.1 to
5.1 in WT vs Fat-1 mice, respectively (P < 0.001; Fig. 1(A)). This
reduction in n-6:n-3 ratio was attributed to a 14% reduction in AA
(22.0e19.0%) and a 5.8-fold increase in n-3 PUFAs (0.67e3.86%).
Thus, while fat-1 expression dramatically reduced the n-6:n-3 ratio
in serum in both sexes, the effect was greater in male mice due to a
greater increase in n-3 PUFA concentrations. Along with the
reduction in the n-6:n-3 PUFA ratio, fat-1 expression also reduced
serum IL-6 and TNF-a levels by approximately 50% and 33%,
respectively, [Fig.1(B), (C)]. For IL-6, fat-1 expression reduced serum
concentrations similarly in male and female mice (52% vs 46%;
Fig.1(B)). For TNF-a, fat-1 expression reduced serum concentrations
to a lesser extent inmalemice (19%) compared to female mice (41%;
Fig. 1(C)). Overall, however, serum cytokine concentrations were
only signiﬁcantly altered by the fat-1 genotype and not gender.
Body mass and glucose tolerance
n-3 PUFAs have previously been shown to promote insulin
signaling in diet-induced obese mice13. Therefore, to investigate
potential links between n-3 mediated changes in metabolism and
knee OA, we tested the effect of fat-1 expression on body mass and
glucose tolerance in aged mice. Male and female mice were
compared separately because body weight is lower in female mice
[Fig. 2(A), (D)]. In male mice, fat-1 expression did not signiﬁcantly
alter body mass [Fig. 2(A)] or glucose tolerance [Fig. 2(B), (C)]. Fat-1expression did not alter body mass or glucose tolerance in female
mice either [Fig. 2(D)e(F)]. Thus, unlikewith obesity13, increased n-
3 PUFAs with fat-1 expression did not improve glucose tolerance in
aged mice.
Effect of fat-1 expression on knee OA in male mice
Cartilage OA changes generally ranged between 25 and 50% of
the maximal OA scores in bothWTand Fat-1 mice, although a small
number of animals developed near maximal OA [Fig. 3(A), (B)].
Typical changes included cartilage loss and ﬁbrillation in the sur-
face zone and focal loss of Safranin-O staining in the central pri-
mary load-bearing regions [Fig. 3(A)]. OA scores were similar
between the femur and tibia in both the medial and lateral com-
partments of WT and Fat-1 animals [Fig. 3(B)]. Furthermore, ge-
notype did not alter any of the sub-component OA scores at these
sites, including cartilage structural damage, tidemark duplication,
Safranin-O staining loss, or hypertrophic chondrocytes. Osteophyte
development was assessed in the anterior and posterior margins in
the medial peripheral tibial plateau. Osteophyte development was
greater in the anterior vs the posterior joint margin in WT animals
[Fig. 3(C)]. A similar trend was observed in Fat-1 mice. Therewas no
effect of fat-1 expression on osteophyte development at either
location [Fig. 3(C)]. Finally, we assessed changes in synovial
morphology by quantifying anterior thickness and the outgrowth
of synovium into the joint space, parallel to the meniscus surface.
While there was a trend for greater synovial thickness in the lateral
compartment, joint compartment and fat-1 transgene expression
did not alter synovial thickness [Fig. 3(D)]. The occurrence of sy-
novial extensions into the joint space was similar in both medial
and lateral compartments and in bothWTand Fat-1mice [Fig. 3(E)].
Effect of fat-1 expression on knee OA in female mice
In female animals, cartilage OA changes generally ranged be-
tween 15 and 30% of the maximal OA scores in both WT and Fat-1
Fig. 3. Fat-1 transgene expression does not alter knee joint OA outcomes in aged male mice. A. Representative sagittal histology sections of the medial knee joint compartment in
WT and Fat-1 male mice. 4 images are from more peripheral medial sections used for osteophyte grading and 40 images are from more central load-bearing regions. Capped
white bar superﬁcial to the anterior horn of the meniscus indicates site of anterior synovial thickness measurement. Asterisks indicate examples of synovial extensions into the joint
space. Black arrows indicate sites of osteophyte evaluation. Black bar ¼ 200 mm in 4 image and 20 mm in 40 image. B. Modiﬁed Mankin OA score of the medial (M) and lateral (L)
tibia (T) and femur (F). Data points are mean values of multiple graded sections for individual animals. Expression of the fat-1 transgene did not alter OA scores at any site. C.
Anterior (Ant) and posterior (Post) medial tibia osteophyte scores for WT and Fat-1 mice. D. Medial and lateral anterior synovial thickness in WT and Fat-1 mice. E. Medial and
lateral synovial extension scores for WT and Fat-1 mice. N ¼ 18, WT; N ¼ 16, Fat-1 for all scores. Bars that do not share the same letter are statistically different from each other
(P < 0.05) as determined by Dunn's multiple comparisons test. Values are mean ± 95% CI.
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maximal [Fig. 4(A), (B)]. Similar to male mice, typical changes
included cartilage loss and ﬁbrillation in the surface zone and focal
loss of Safranin-O staining in the central primary load-bearing re-
gions [Fig. 4(A)]. Although not statistically signiﬁcant, tibial OA
scores tended to be greater than femoral scores in both the medial
and lateral compartments of WT and Fat-1 animals [Fig. 4(B)].
Genotype did not signiﬁcantly alter the overall OA score or any of
the sub-component OA scores at any of the sites with the exception
of hypertrophic chondrocytes. In the medial tibia, Fat-1 mice
developed fewer hypertrophic chondrocytes than WT mice
(1.5 ± 0.1 vs 1.0 ± 0.1; P ¼ 0.016). As in male mice, osteophyte
development was greater in the anterior vs the posterior medial
peripheral joint margin, although in female mice this was true for
both WT and Fat-1 mice [Fig. 4(C)]. Similarly, though, there was no
effect of fat-1 expression on osteophyte development at either
location [Fig. 4(C)]. In the synovium, the anterior thickness was 87%and 77% thicker in the lateral vs the medial compartment for WT
and Fat-1 mice, respectively (Fig. 4(D); P < 0.001 for both geno-
types). The number of synovial extensions into the joint space was
also signiﬁcantly greater in the lateral compartment for both ge-
notypes (P < 0.001; Fig. 4(E)). However, there was no effect of fat-1
expression on synovial thickness or synovial extensions in any
location.
Subchondral cortical and trabecular bone
Both the morphology and density of the tibial subchondral
cortical and trabecular bone were examined for male and female
WTand Fat-1mice (Fig. 5). Subchondral cortical bone thickness was
signiﬁcantly greater in the medial vs the lateral tibial plateau in
both male [Fig. 5(A)] and female [Fig. 5(B)] animals (27% and 19%,
respectively). The reduced subchondral bone thickness in the
lateral compartment was associated with an 8% lower bonemineral
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Fig. 4. Fat-1 transgene expression does not substantially alter knee joint OA outcomes in aged female mice. A. Representative sagittal histology sections of the medial knee joint
compartment in WT and Fat-1 female mice. 4 images are from more peripheral medial sections used for osteophyte grading and 40 images are from more central load-bearing
regions. Black arrows indicate anterior osteophytes. Black bar ¼ 200 mm in 4 image and 20 mm in 40 image. B. Modiﬁed Mankin OA score of the medial (M) and lateral (L) tibia (T)
and femur (F). Data points are mean values of multiple graded sections for individual animals. Expression of the fat-1 transgene did not alter OA scores at any site. C. Anterior (Ant)
and posterior (Post) medial tibia osteophyte scores for WT and Fat-1 mice. D. Medial and lateral anterior synovial thickness in WT and Fat-1 mice. E. Medial and lateral synovial
extension scores for WT and Fat-1 mice. N ¼ 10, WT; N ¼ 10, Fat-1. Bars that do not share the same letter are statistically different from each other (P < 0.05) as determined by
Dunn's multiple comparisons test. Values are mean ± 95% CI.
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transgene expression did not alter any subchondral cortical bone
parameters in male or female mice. Medial vs lateral differences
were also observed in the trabecular bone parameters, although
these differences were primarily restricted to male mice [Fig. 5(C),
(D)]. For both WT and Fat-1 male mice, the lateral trabecular bone
compartment, compared to the medial compartment, had a lower
relative trabecular bone volume (BV/TV), lower bone mineral
density, reduced trabecular bone thickness, and increased trabec-
ular spacing [(Fig. 5(C)]. Nomedialelateral differences in trabecular
bone parameters were detected in female mice, except for an 11%
reduction in trabecular thickness in the lateral trabecular
compartment of Fat-1 mice (P < 0.05; Fig. 5(D)).Effect of fat-1 expression on the association of OA outcome markers
in cartilage, synovium, and bone
To further investigate the potential effect of a reduction in the n-
6:n-3 ratio on OA-related outcomes, we conducted multivariable
analyses to determine if adjusting for the fat-1 genotype or sexaltered the associations between modiﬁed Mankin OA scores and
each of the following bone parameters: osteophyte score, sub-
chondral bone thickness, and relative trabecular bone volume (BV/
TV). We repeated these models for synovial thickness as the
outcome measure. Including sex and genotype in the regression
analyses did not result in signiﬁcant associations between any of
the bone-related parameters and the cartilage OA score or synovial
thickness. In each model, though, sex had a signiﬁcant effect on the
relationship between bone phenotypes and cartilage OA or syno-
vium outcome measures. Genotype, however, was not a signiﬁcant
parameter for any of the models (data not shown). Thus, a reduc-
tion in the n-6:n-3 ratio by expression of the fat-1 transgene did not
alter the association between bone phenotypes and cartilage OA
scores or synovium thickness.Discussion
We hypothesized that a low ratio of n-6:n-3 PUFAs caused by
expression of the fat-1 transgene would protect against idiopathic
OA development in cartilage and synovium, but not bone. However,
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Fig. 5. Fat-1 transgene expression does not alter proximal tibial subchondral or trabecular bone morphology or density in male and female mice. Micro-CT evaluation of the
proximal tibial plateau and epiphysis was used to examine effects of fat-1 transgene expression on the bony changes related to knee OA. Medial and lateral subchondral bone
thickness and bone mineral density were compared by genotype in male A and female B mice. Relative trabecular bone volume and trabecular bone density, thickness, and spacing
were also compared in medial and lateral compartments in WT and Fat-1 male C and female D mice. Genotype did not alter any of the bone morphology or density outcome
measures. Differences between the medial and lateral compartments were observed for several subchondral and trabecular bone measures in both male and female mice, as
indicated by bars that do not share the same letter (P < 0.05). Graphs without letters contain no signiﬁcant group differences. Sample size: Males (N ¼ 10, WT; N ¼ 9, Fat-1);
Females (N ¼ 10 for WT and Fat-1). Values are mean ± 95% CI.
A. Cai et al. / Osteoarthritis and Cartilage 22 (2014) 1301e1309 1307our results do not support this hypothesis. Despite a signiﬁcant,
albeit moderate, reduction in the systemic inﬂammatory cytokines
TNF-a and IL-6 in Fat-1 mice, there were no signiﬁcant differences
in glucose tolerance and the development of spontaneous knee OA.
In fact, in nearly every OA related outcome examined, mice
expressing the fat-1 transgene were indistinguishable from WT
mice. Moreover, when statistically controlling for differences be-
tween male and female mice, there was no effect of the fat-1
transgene on associations between cartilage and bone or synovium
and bone OA-related outcomes. Thus, a life-long reduction in the n-
6:n-3 ratio does not alter the development of idiopathic early to
moderate stage knee OA in middle-aged mice.
These ﬁndings suggest that a systemic shift in the relative levels
of n-6 and n-3 PUFAs has a minimal effect on normal joint devel-
opment and remodeling. This is surprising because n-3 PUFAs are
ligands for the nuclear transcription factors peroxisome pro-
liferator activated receptor-gamma and retinoid X receptor33,
which regulate cartilage development and homeostasis34,35. In
addition, autophagy, which is implicated in aging-associated OA36,
is up-regulated in Fat-1 mice following joint injury21. The absence
of a protective effect of the fat-1 transgene on idiopathic OA is also
surprising because n-3 PUFAs inhibit the activity of pro-
inﬂammatory IKKb/NFkB and JNK/AP1 signaling pathways13. In
chondrocytes, IKKb/NFkB and JNK/AP1 are critical inﬂammatory
and mechanosensitive signaling pathways involved in regulatingcatabolic gene expression5,37,38. n-3 PUFAs inhibit these pathways
directly through ligand-mediated activation of GPR120 and
downstream inactivation of transforming growth factor-b activated
kinase 1 (TAK1)13. Chondrocytes express GPR12039, but the physi-
ological relevance of GPR120-mediated inactivation of TAK1 in
articular chondrocytes is unknown.
With knee OA, the rate of subchondral bone remodeling in-
creases40 resulting in altered subchondral cortical and trabecular
bone volume, morphology, and mineral content depending on the
stage of disease41. Previous studies indicate that n-3 PUFAs reduce
bone absorption42 and increase bone mass and strength26,43,
including protection against ovariectomy-induced bone loss in
mice supplemented with an n-3 PUFA enriched diet44 or in fat-1
transgene mice27. Therefore, the absence of any changes in sub-
chondral bone parameters in Fat-1micewas unexpected. A reduced
ratio of n-6:n-3 PUFAs may alter skeletal disease pathology in post-
traumatic OA models involving higher rates of bone remodeling.
There are several limitations of the current study. First, we do
not know the extent to which n-6 and n-3 PUFAs were altered in
the joint tissues of Fat-1 mice. Previous studies suggest less
reduction in the n-6:n-3 ratio in cartilage (57%)21 compared to
muscle (96%)22 and bone (99%)26 based on a ratio of AA/
(EPA þ Docosapentaenoic acid (DPA) þ DHA). The beneﬁcial effects
of n-3 PUFAs using dietary supplements may achieve lower n-6:n-3
ratios. Bhattacharya and colleagues25 observed a beneﬁcial effect of
A. Cai et al. / Osteoarthritis and Cartilage 22 (2014) 1301e13091308n-3 PUFAs on reducing inﬂammation and osteoclastogenesis in
aging mice by manipulating the n-6:n-3 ratio using corn vs ﬁsh oil
supplements. The ﬁsh oil supplement group obtained a serum n-
6:n-3 ratio of 0.41, which is lower than we observed in Fat-1 mice.
However, dietary supplements can also alter the macronutrient
composition of diets, which may contribute to differences in study
outcomes. An advantage of the fat-1 transgene for mechanistic
studies is that Fat-1 and WT littermate mice are fed the same diet
and exposed to the same environmental conditions due to co-
housing, factors which may contribute to differences in the devel-
opment of idiopathic OA45.
An additional limitation is that we did not examine older ani-
mals with more advanced OA. n-3 PUFAs inhibit inﬂammation and
accelerate the resolution of inﬂammation13,14; however, the
involvement of immune cell mediated cytokine signaling in mild to
moderate idiopathic OA is not well-established in C57BL/6 mice.
Analysis of older animals with more severe OA or in combination
with post-traumatic models of OA21 may be required to reveal the
beneﬁcial effects of n-3 PUFAs with aging. A recent study reported
that DHA supplementation reduces nociception and inﬂammation
in an inﬂammatory mouse model of knee arthritis46. Thus, OA sub-
types involving more active synovial inﬂammation may beneﬁt
from increased levels of n-3 PUFAs as suggested in individuals that
have or are at high risk for developing knee OA19.
In summary, a life-long reduction in the ratio of n-6:n-3 PUFAs
causes a modest decrease in systemic TNF-a and IL-6 but does not
alter the early-stage development of idiopathic knee OA in aging
Fat-1 mice; 9e14 month-old male and female Fat-1 mice develop
cartilage degeneration and osteophyte formation at levels compa-
rable toWTmice. Furthermore, subchondral cortical and trabecular
bonemorphology and bonemineral density are similar in Fat-1 and
age-matched WT mice. Overall, these ﬁndings suggest that high
levels of n-6 relative to n-3 PUFAs do not exacerbate idiopathic
changes in joint tissue homeostasis that initiate the development of
knee OA. The anti-inﬂammatory and anti-catabolic effects of n-3
PUFAs previously reported for cartilage appear to be more evident
in post-traumatic and other more inﬂammatory models of OA.Author contributions
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